SPIRIVA RESPIMAT (tiotropium bromide) is indicated for the long- term, once-daily, maintenance treatment of bronchospasm Ridgefield, Conn
Tiotropium has been extensively studied in clinical trials and proven to prevent the progression of obstructive lung disease and these complications
FDA) for its Abbreviated New Drug Application for Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, a generic equivalent of Spiriva®
5 µg each) for the U
It works by relaxing the Draft Guidance on Tiotropium Bromide November 2023 This draft guidance, when finalized, will represent the current thinking of the Food and Drug Administration (FDA, or the Agency) on this Tiotropium bromide inhalation powder is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including 2 DOSAGE AND ADMINISTRATION For
Tiotropium bromide inhalation powder is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema
Strength: EQ 0
5 mcg tiotropium bromide monohydrate) blended with lactose monohydrate (which may contain milk proteins) as the carrier
Common Spiriva side effects may include: dry mouth; blurred vision; constipation, painful urination; upset stomach; chest pain, fast heart rate; or
Spiriva; Spiriva Respimat; Descriptions
Cognitive issues, such as memory loss, “brain fog,” schizophrenia and learning disabilities in children
It works by blocking the muscarinic receptors in airway smooth muscle
stomach discomfort, upset, or pain
This is not a complete list of side effects and others may occur
Drug, and Cosmetic Act (FD&C Act) for Tiotropium Bromide Inhalation Powder, 18 mcg/capsule
Avoid administration of SPIRIVA HANDIHALER with other anticholinergic-containing drugs
PIV Results: 0 2 4 6 8 10 12 14 16 18 103 medications are known to interact with tiotropium
The drug substance, tiotropium bromide monohydrate, is an anticholinergic with specificity for muscarinic receptors
For asthma: For oral inhalation dosage form (spray): Adults and children 6 years of age and older—2 puffs once a day
The STIOLTO RESPIMAT cartridge is intended only for use with the STIOLTO RESPIMAT inhaler
umeclidinium bromide/vilanterol inhaled
Name Tiotropium bromide Drug Entry Tiotropium